South Denver Cardiology
Back to Trials

Evolve Short DAPT

Short Description

Study designed to assess the safety of 3-month dual antiplatelet therapy.

Evolve Short DAPT:  A prospective, multicenter, single-arm study designed to assess the safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk for bleeding undergoing percutaneous intervention with the SYNERGY Stent System.  Done only at SMC

Questions: Call Mary Soltau 303-703-2191 or Rebecca Wimmer 303-715-2275

South Denver Cardiology
Latest posts by South Denver Cardiology (see all)

Recommend

  • This field is for validation purposes and should be left unchanged.
  • MM slash DD slash YYYY
  • What questions do you have regarding your bill?